Treffer 1 - 1 von 1 für Suche 'Rosti, Gianatonio', Suchdauer: 0,32s
Treffer weiter einschränken
-
1
Long term outcome of Ph+ CML patients achieving complete cytogenetic remission with interferon based therapy moving from interferon to imatinib era von Malagola, Michele, Breccia, Massimo, Skert, Cristina, Cancelli, Valeria, Soverini, Simona, Iacobucci, Ilaria, Cattina, Federica, Liberati, Anna Maria, Tiribelli, Mario, Annunziata, Mario, Trabacchi, Elena, Vivo, Antonio, Castagnetti, Fausto, Martinelli, Giovanni, Fogli, Miriam, Stagno, Fabio, Pica, Gianmatteo, Iurlo, Alessandra, Pregno, Patrizia, Abruzzese, Elisabetta, Pardini, Simonetta, Bocchia, Monica, Russo, Sabina, Pierri, Ivana, Lunghi, Monia, Barulli, Sara, Merante, Serena, Mandelli, Franco, Alimena, Giuliana, Rosti, Gianatonio, Baccarani, Michele, Russo, Domenico
Veröffentlicht in American journal of hematology
VolltextArtikel
Suchwerkzeuge:
Treffer weiter einschränken
Seite wird neu geladen, wenn Filter aktiviert oder ausgeschlossen wird.- Adult 1 Treffer 1
- Aged 1 Treffer 1
- Antineoplastic Agents - Administration & Dosage 1 Treffer 1
- Antineoplastic Agents - Therapeutic Use 1 Treffer 1
- Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use 1 Treffer 1
- Benzamides - Administration & Dosage 1 Treffer 1
- Benzamides - Therapeutic Use 1 Treffer 1
- Cross-Sectional Studies 1 Treffer 1
- Drug Substitution 1 Treffer 1
- Female 1 Treffer 1
- Follow-Up Studies 1 Treffer 1
- Fusion Proteins, Bcr-Abl - Genetics 1 Treffer 1
- Hematology 1 Treffer 1
- Humans 1 Treffer 1
- Imatinib Mesylate 1 Treffer 1
- Interferon-Alpha - Administration & Dosage 1 Treffer 1
- Interferon-Alpha - Therapeutic Use 1 Treffer 1
- Leukemia, Myelogenous, Chronic, Bcr-Abl Positive - Drug Therapy 1 Treffer 1
- Leukemia, Myelogenous, Chronic, Bcr-Abl Positive - Genetics 1 Treffer 1
- Leukemia, Myelogenous, Chronic, Bcr-Abl Positive - Mortality 1 Treffer 1